Results 201 to 210 of about 111,141 (252)

Preoperative Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Arterial Enhancement Fraction Derived From Dual‐Layer Spectral CT

Head &Neck, EarlyView.
ABSTRACT Objective To evaluate the diagnostic value of arterial enhancement fraction (AEF) derived from dual‐layer detector spectral CT (DLCT) in preoperative assessment of cervical lymph node metastasis in patients with papillary thyroid carcinoma (PTC), and to compare its performance with other spectral CT quantitative parameters and conventional CT ...
Lili Ye, Xiangfa He, Ming Liang, Yuxin Wei, Hao Zhang, Xiaomin Liu, Xiaolin Zheng   +6 more
wiley   +1 more source

Head and Neck Lymph Node Metastases From Cancer of Unknown Primary: Outcomes From p16‐Guided Mucosal Radiotherapy

Head &Neck, EarlyView.
ABSTRACT Background The AJCC 8th edition distinguishes p16‐positive oropharyngeal head and neck carcinoma of unknown primary (HNCUP) due to its superior prognosis. However, standardized radiation volume guidelines are lacking. This study evaluates the safety of p16‐guided mucosal volume reduction.
Philippe Harris, Dhiya‐Eddine Mabrouki, Felix‐Phuc Nguyen‐Tan, Edith Filion, Olivier Ballivy, Brian O'Sullivan, Apostolos Christopoulos, Tareck Ayad, Louis Guertin, Eric Bissada, Paul Tabet, Denis Soulières, Antoine Desilets, Alexandre Pellan Cheng, Robert Doucet, Laurent Létourneau‐Guillon, Houda Bahig   +16 more
wiley   +1 more source

Risk Stratification or Disease Staging? Re-Evaluating the Evidence Base for Neoplastic Gallbladder Polyp Management. [PDF]

Korean J Radiol
Liu H, Liu X.
europepmc   +1 more source

Surgery After Thermal Ablation of Thyroid Nodules: A Systematic Review of Surgical Risk, Strategy and Pathological Findings

Head &Neck, EarlyView.
ABSTRACT Background Thermal ablation is increasingly used for selected thyroid nodules, but some patients subsequently require thyroidectomy. The effect of prior ablation on surgical risk, operative strategy, and histopathology remains unclear. Methods PubMed/MEDLINE, EMBASE, and the Cochrane Library were searched from inception to May 2026 for studies
Francesco Brucchi, Federica Poli, Beatrice Sperotto, Carla Colombo, Laura Fugazzola, Gianlorenzo Dionigi   +5 more
wiley   +1 more source

Clinical Trial Protocol for LPS-Boost: Intensified [¹⁷⁷Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease. [PDF]

J Nucl Med
Iravani A, Gulati R, Miyaoka R, Reiger AC, Chen DL, Kumar M, Erickson M, Nega K, Meyer C, Lira S, Seo Y, Flavell RR, Pritchard CC, Haffner MC, Nadal Rios R, Sunkara R, Khan HM, Yezefski T, Raychaudhuri R, Hsieh AC, Grivas P, Cheng HH, Yu EY, Schweizer MT, Nelson PS, Czernin J, Hope TA, Calais J.   +27 more
europepmc   +1 more source

Finding My Path: Listening, Learning, and Leading in Rare Disease: The 2025 Hower Award

Annals of the Child Neurology Society, EarlyView.
Andrea Gropman
wiley   +1 more source

Correction: Perivascular diffusion and white matter free water improve identification of cognitive impairment in cerebral small vessel disease. [PDF]

Front Neurol
Yang C, Cai S, Wang B, Zhou J, Wu D, Li M, Geng W, Wu L, Peng K, Yang Y, Gu W.   +10 more
europepmc   +1 more source

Corrigendum to "4D Flow cardiovascular magnetic resonance consensus statement: 2023 update" [Journal of Cardiovascular Magnetic Resonance 25 (2023) 40]. [PDF]

J Cardiovasc Magn Reson
Bissell MM, Raimondi F, Ali LA, Allen BD, Barker AJ, Bolger A, Burris N, Carlhäll CJ, Collins JD, Ebbers T, Francois CJ, Frydrychowicz A, Garg P, Geiger J, Ha H, Hennemuth A, Hope MD, Hsiao A, Johnson K, Kozerke S, Ma LE, Markl M, Martins D, Messina M, Oechtering TH, van Ooij P, Rigsby C, Rodriguez-Palomares J, Roest AAW, Roldán-Alzate A, Schnell S, Sotelo J, Stuber M, Syed AB, Töger J, van der Geest R, Westenberg J, Zhong L, Zhong Y, Wieben O, Dyverfeldt P.   +40 more
europepmc   +1 more source

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

International Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto, Sophie Gibert, Caroline Delmas, David Tougeron, Amaury Paumier, Alexandre Taillez, Samuel Le Sourd, Delphine Argo Leignel, Philippe Ronchin, Ariane Darut Jouve, Véronique Vendrely, Olivier Riou, Jérôme Martin‐Babau, Thomas Leroy, Laurent Quéro, Naïma Hanoun, Pierre Cordelier, Veronica Pezzella, Jean Pierre Delord, Rosine Guimbaud, Elizabeth Moyal, Catherine Seva   +21 more
wiley   +1 more source

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[¹⁸F]FDG PET-Negative Marrow: Results From an International Retrospective Study. [PDF]

J Clin Oncol
Mercolini F, Just M, Shulkin BL, Collins NB, Crane J, Harrison D, Affinita MC, Allen-Rhoades W, Alessi A, Asaftei SD, Arnold MA, Chen S, Chiaravalli S, FitzGerald F, Freitag MT, Iftner JL, Khalatbari H, de Keizer B, von Luettichau I, Mauz-Körholz C, Rossig C, Rovera G, Rutkowski S, Sims JB, Voss SD, Yoshimi A, Birz S, Bisogno G, Ebinger M, Merks JHM, Sparber-Sauer M, Haller B, Weiss AR, Linardic CM, Schoot RA, Hettmer S, INSTRuCT Imaging/Pathology/Biology Network.   +36 more
europepmc   +1 more source